Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Core Laboratories Inc (NYSE: CLB) closed at $13.44 down -9.92% from its previous closing price of $14.92. In other words, the price has decreased by -$9.92 from its previous closing price. On the day, 0.69 million shares were traded. CLB stock price reached its highest trading level at $14.23 during the session, while it also had its lowest trading level at $12.77.
Ratios:
For a deeper understanding of Core Laboratories Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 32.76 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.68. For the most recent quarter (mrq), Quick Ratio is recorded 1.71 and its Current Ratio is at 2.32. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.67.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Citigroup on March 12, 2025, Upgraded its rating to Neutral and sets its target price to $16 from $15 previously.
On June 30, 2023, Citigroup Downgraded its rating to Sell which previously was Neutral and also lowered its target price recommendation from $22 to $21.
BofA Securities Downgraded its Neutral to Underperform on April 18, 2023, while the target price for the stock was maintained at $21.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLB now has a Market Capitalization of 627677568 and an Enterprise Value of 796084480. As of this moment, Core’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.45, and their Forward P/E ratio for the next fiscal year is 12.92. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.20 while its Price-to-Book (P/B) ratio in mrq is 2.50. Its current Enterprise Value per Revenue stands at 1.52 whereas that against EBITDA is 11.872.
Stock Price History:
The Beta on a monthly basis for CLB is 1.42, which has changed by -0.22446626 over the last 52 weeks, in comparison to a change of 0.036926866 over the same period for the S&P500. Over the past 52 weeks, CLB has reached a high of $25.13, while it has fallen to a 52-week low of $12.95. The 50-Day Moving Average of the stock is -16.25%, while the 200-Day Moving Average is calculated to be -28.12%.
Shares Statistics:
For the past three months, CLB has traded an average of 337.49K shares per day and 393650 over the past ten days. A total of 46.83M shares are outstanding, with a floating share count of 46.35M. Insiders hold about 1.01% of the company’s shares, while institutions hold 108.90% stake in the company. Shares short for CLB as of 1741910400 were 6532968 with a Short Ratio of 19.36, compared to 1739491200 on 6073941. Therefore, it implies a Short% of Shares Outstanding of 6532968 and a Short% of Float of 27.07.
Dividends & Splits
According to the company, the forward annual dividend rate for CLB is 0.04, from 0.04 in the trailing year. Against a Trailing Annual Dividend Yield of 0.002680965The stock’s 5-year Average Dividend Yield is 0.83. The current Payout Ratio is 5.97% for CLB, which recently paid a dividend on 2025-02-10 with an ex-dividend date of 1739145600. Stock splits for the company last occurred on 2010-07-09 when the company split stock in a 2:1 ratio.
